Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacque, Emilie, Chottin, Claire, Laubreton, Daphné, Nogre, Michel, Ferret, Cécile, de Marcos, Sandrine, Baptista, Linda, Drajac, Carole, Mondon, Philippe, De Romeuf, Christophe, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Chtourou, Sami, Riffault, Sabine, Perret, Gérald, Descamps, Delphyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://www.ncbi.nlm.nih.gov/pubmed/34163482
http://dx.doi.org/10.3389/fimmu.2021.683902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://www.ncbi.nlm.nih.gov/pubmed/34163482
http://dx.doi.org/10.3389/fimmu.2021.683902

Ejemplares similares